会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • CORTICOTROPIN RELEASING FACTOR ANTAGONISTS
    • CORTICOTROPIN释放因子拮抗剂
    • WO2002100863A1
    • 2002-12-19
    • PCT/GB2002/002656
    • 2002-06-11
    • GLAXO GROUP LIMITEDDI FABIO, RomanoMARCHIONNI, ChiaraMICHELI, FabrizioPASQUARELLO, AlessandraPERINI, BenedettaST-DENIS, Yves
    • DI FABIO, RomanoMARCHIONNI, ChiaraMICHELI, FabrizioPASQUARELLO, AlessandraPERINI, BenedettaST-DENIS, Yves
    • C07D487/04
    • C07D487/04A61K51/0459C07B2200/05C07D239/70C07D239/94C07D471/04
    • The present invention provides compounds of formula (I) including stereoisomers, prodrugs and pharmaceutically acceptable salts or solvates thereof, wherein R is aryl or heteroaryl and each of the above groups R may be substituted by 1 to 4 groups selected from: halogen, C1-C6 alkyl, C1-C6 alkoxy, halo C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halo C1-C6 alkoxy, -COR 4 , nitro, -NR 3 R 4 cyano, or a group R 5 ; R 1 is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halo C1-C6 alkyl, halo C1-C6 alkoxy, halogen, NR 3 R 4 or cyano; R 2 corresponds to a group CHR 6 R 7 ; R 3 is hydrogen, C1-C6 alkyl; R 4 independently from R 3 , has the same meanings; R 5 is C3-C7 cycloalkyl, which may contain one or more double bonds; aryl; or a 5-6 membered heterocycle; wherein each of the above groups R 5 may be substituted by one or more groups selected from: halogen, C1-C6 alkyl, C1-C6 alkoxy, halo C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halo C1-C6 alkoxy, C1-C6 dialkylamino, nitro or cyano; R 6 is hydrogen, C2-C6 alkenyl or C1-C6 alkyl, wherein each of the above groups R 6 may be substituted by one or more groups selected from: C1-C6 alkoxy and hydroxy; R 7 independently from R 6 , has the same meanings; X is carbon or nitrogen; to processes for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of conditions mediated by corticotropin-releasing factor (CRF).
    • 本发明提供式(I)化合物,其包括立体异构体,其前药和药学上可接受的盐或溶剂化物,其中R是芳基或杂芳基,并且上述基团中的每一个R可以被1至4个选自以下的基团取代:卤素, C 1 -C 6烷基,C 1 -C 6烷氧基,卤代C 1 -C 6烷基,C 2 -C 6烯基,C 2 -C 6炔基,卤代C 1 -C 6烷氧基,-COR 4,硝基,-NR 3 R 4氰基或基团R 5; R 1是氢,C 1 -C 6烷基,C 2 -C 6烯基,C 2 -C 6炔基,卤代C 1 -C 6烷基,卤代C 1 -C 6烷氧基,卤素,NR 3 R 4或氰基; R2对应于CHR6R7基团; R3是氢,C1-C6烷基; R4独立于R3,具有相同的含义; R5是C3-C7环烷基,其可以含有一个或多个双键; 芳基; 或5-6元杂环; 其中上述基团R 5可以被一个或多个选自以下的基团取代:卤素,C 1 -C 6烷基,C 1 -C 6烷氧基,卤代C 1 -C 6烷基,C 2 -C 6烯基,C 2 -C 6炔基,卤代C 1 -C 6 烷氧基,C1-C6二烷基氨基,硝基或氰基; R 6是氢,C 2 -C 6烯基或C 1 -C 6烷基,其中上述基团R 6可以被一个或多个选自:C 1 -C 6烷氧基和羟基的基团取代; R7独立于R6,具有相同的含义; X是碳或氮; 其制备方法,含有它们的药物组合物及其用于治疗由促肾上腺皮质激素释放因子(CRF)介导的病症的用途。